Efstathiadou Zoe A, Kita Marina D, Polyzos Stergios A
Department of Endocrinology, Hippokration General Hospital, Thessaloniki, Greece -
Department of Endocrinology, Hippokration General Hospital, Thessaloniki, Greece.
Minerva Endocrinol. 2018 Sep;43(3):367-376. doi: 10.23736/S0391-1977.17.02617-7. Epub 2017 Feb 9.
Thyroid hormones are crucial for hepatic lipid and glucose metabolism. Non-alcoholic fatty liver disease (NAFLD), a very common and potentially serious disease of modern society, shares common clinical features with hypothyroidism, such as obesity, insulin resistance and dyslipidemia. Furthermore, in certain studies, increased prevalence of hypothyroidism was observed in patients with NAFLD. However, whether there is a linear relationship between thyroid hormone levels, including values within or in proximity to the reference range and NAFLD incidence and severity remains a contradictory subject in the literature. On the other hand, attempts to treat NAFLD with thyromimetic drugs remain at an early stage. In this review, data derived from observational studies along with evidence on possible treatment with thyroid hormone analogues are presented.
甲状腺激素对肝脏脂质和葡萄糖代谢至关重要。非酒精性脂肪性肝病(NAFLD)是现代社会一种非常常见且可能严重的疾病,与甲状腺功能减退症有共同的临床特征,如肥胖、胰岛素抵抗和血脂异常。此外,在某些研究中,观察到NAFLD患者甲状腺功能减退症的患病率增加。然而,甲状腺激素水平(包括参考范围内或接近参考范围的值)与NAFLD发病率和严重程度之间是否存在线性关系在文献中仍是一个存在争议的问题。另一方面,用拟甲状腺药物治疗NAFLD的尝试仍处于早期阶段。在本综述中,展示了来自观察性研究的数据以及关于甲状腺激素类似物可能治疗的证据。